Christophe Arbet-Engels, M.D., Ph.D.
Dr. Arbet-Engels joined Millendo in February 2020 as Chief Medical Officer bringing to the company more than 25 years of experience in life sciences, academia and industry.
Dr. Arbet-Engels was most recently at Poxel Pharmaceuticals where he was Chief Medical Officer, Executive Vice President Late Development and Medical Affairs with responsibility for all medical activities for Poxel’s portfolio, including driving portfolio strategy and execution of registration programs. Previously, he served as Vice President, Worldwide Medical, Collaborative Medical Sciences at Biogen where Dr. Arbet-Engels built, developed and led global medical research, clinical operations, biostatistics/analytics, communication and expanded access program teams to advance the medical sciences in multiple therapeutic areas.
Dr. Arbet-Engels has also held several senior leadership positions, globally and locally, in clinical development and medical affairs at pharmaceutical and biotech companies including Boehringer Ingelheim, Roche, Merck, Aventis (now Sanofi) and Ligand Pharmaceuticals where he led the clinical development and registration, launch and lifecycle management for several new medicines. In addition, Dr. Arbet-Engels works as French Foreign Trade Advisor for the French Government to advise, support and mentor French or other startup companies to develop their businesses in the U.S.
Dr. Arbet-Engels has a medical degree from University of Paris Sud, a Ph.D. in endocrinology/diabetes and metabolism from Paris Descartes University and a master’s degree in business administration from Rutgers University.